Profile picture for Caoilfhionn Marie Connolly, MD

Caoilfhionn Marie Connolly, MD

Dr. Caoilfhionn Marie Connolly is a Consultant Rheumatologist at the Galway Clinic, Blackrock Health, Ireland. She completed internal medicine residency, followed by fellowships in rheumatology and advanced myositis at the Johns Hopkins Hospital.

Widely recognized for her clinical and academic excellence, she was awarded the 2023 American College of Rheumatology Distinguished Fellow Award. Dr. Connolly has published extensively in leading journals, including the New England Journal of Medicine, Annals of Internal Medicine, Lancet Rheumatology, and Annals of Rheumatic Diseases.  Dr. Connolly’s passions include medical education for both patients and physicians alike, as well as driving advancements in rheumatology, particularly in the treatment of complex inflammatory conditions. You can follow her on X at @caoilfhionnmd.

Articles By Caoilfhionn Marie Connolly, MD

Rheumatoid,RA,nodules,damage

ICYMI: Shifting Trends in Initial RA Treatment Approaches

By Caoilfhionn Marie Connolly, MD

A recent study by Sparks et al reveals evolving trends in DMARD usage for rheumatoid arthritis over two decades in the United States. This retrospective analysis evaluated 407,728 DMARD initiation episodes among 229,365 unique patients from 2001 to 2021.

Read Article
PsA.Hands_.jpg

Diagnostic Delays in PsA

By Caoilfhionn Marie Connolly, MD

Despite the remarkable expansion of the therapeutic armamentarium for psoriatic arthritis (PsA), the MONITOR-PsA study highlights a persistent and critical issue: delays in diagnosis. The study findings are stark, with about 25% of patients having erosions at diagnosis.

Read Article
bathroom scale

Shedding Weight and Pain: The Promise of Anti-Obesity Medications in RA

By Caoilfhionn Marie Connolly, MD

With the advent of FDA-approved anti-obesity medications such as semaglutide and tirzepatide, a new avenue for managing this challenging patient population has emerged. But how might these drugs impact the trajectory of RA, and are we on the cusp of a paradigm shift?

Read Article
Rheumatoid,RA,nodules,damage

Shifting Trends in Initial RA Treatment Approaches

By Caoilfhionn Marie Connolly, MD

A recent study by Sparks et al reveals evolving trends in DMARD usage for rheumatoid arthritis over two decades in the United States. This retrospective analysis evaluated 407,728 DMARD initiation episodes among 229,365 unique patients from 2001 to 2021.

Read Article
×